A 55-year-old with PAD and diabetes is on low-dose rivaroxaban 2.5 mg BID plus aspirin. He asks about bleeding precautions. Which is true?...

Question

A 55-year-old with PAD and diabetes is on low-dose rivaroxaban 2.5 mg BID plus aspirin. He asks about bleeding precautions. Which is true?

Accepted Answer

Therapy lowers MACE/MALE but increases bleeding; shared decision-making and GI protection may be considered

Answer

Bleeding risk is unchanged

Answer

Stop therapy if any bruising occurs

Answer

Switch to full-dose rivaroxaban to reduce bleeding

Answer

Add clopidogrel to reduce bleeding risk

us-abfm MCQ (SBA): Bleeding Risk in Dual-Pathway Inhibition